IL6 and neoplasm: Chrzanowska and colleagues developed ciprofloxacin-fatty acid conjugates that notably decreased IL-6 secretion in cancer cells, potentially inhibiting tumor progression and inflammation-associated cancer development (Figure 3D) [16].